Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme
Class IITerminatedD-0875-2022

Drug recall · May 25, 2022

GaviLyte -C recall

Why: Failed Stability Specification

Class II: could cause temporary or reversible health problems; serious harm is remote.

The recall

Product

GaviLyte -C (Polyethylene Glycol 3350, 240 g) and electrolytes for Oral Solution, USP with flavor pack NDC# 43386-060-19

Lots / codes

Lot # S001132, exp. date July 2022 NDC # 43386-060-19

Quantity
26,910 bottles
Company
Lupin Pharmaceuticals Inc., Baltimore, MD
Distribution
Product was distributed nationwide, including Puerto Rico.
Initiated
April 27, 2022 · Voluntary: Firm initiated
Classified
May 16, 2022
Reported
May 25, 2022
Ended
April 13, 2023
How notified
Letter

The drug: prices, other makers, shortages

If you have this product

  1. Check the lot number on your package against the lots above. Only those lots are recalled.
  2. Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
  3. Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
  4. Return or dispose of recalled product as the company or your pharmacy advises.

Questions about this recall

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Watch GaviLyte-C

One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.